BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27837233)

  • 1. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study.
    Lankelma JM; van Vught LA; Belzer C; Schultz MJ; van der Poll T; de Vos WM; Wiersinga WJ
    Intensive Care Med; 2017 Jan; 43(1):59-68. PubMed ID: 27837233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study.
    Aardema H; Lisotto P; Kurilshikov A; Diepeveen JRJ; Friedrich AW; Sinha B; de Smet AMGA; Harmsen HJM
    Front Cell Infect Microbiol; 2019; 9():467. PubMed ID: 32010644
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Jung JY; Ahn Y; Khare S; Gokulan K; Piñeiro SA; Cerniglia CE
    Anaerobe; 2018 Feb; 49():85-94. PubMed ID: 29294359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
    Chernevskaya E; Beloborodova N; Klimenko N; Pautova A; Shilkin D; Gusarov V; Tyakht A
    Crit Care; 2020 Jun; 24(1):312. PubMed ID: 32513224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
    Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
    Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota alterations in critically ill older patients: a multicenter study.
    Victoria M; Elena VB; Amparo GN; María JA; Adriana GV; Irene AC; Alejandra YM; Janeth BB; María AG
    BMC Geriatr; 2022 Apr; 22(1):373. PubMed ID: 35484500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child.
    Wijeyesekera A; Wagner J; De Goffau M; Thurston S; Rodrigues Sabino A; Zaher S; White D; Ridout J; Peters MJ; Ramnarayan P; Branco RG; Torok ME; Valla F; Meyer R; Klein N; Frost G; Parkhill J; Holmes E; Pathan N
    Crit Care Med; 2019 Sep; 47(9):e727-e734. PubMed ID: 31169619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis.
    Agudelo-Ochoa GM; Valdés-Duque BE; Giraldo-Giraldo NA; Jaillier-Ramírez AM; Giraldo-Villa A; Acevedo-Castaño I; Yepes-Molina MA; Barbosa-Barbosa J; Benítez-Paéz A
    Gut Microbes; 2020 Nov; 12(1):1707610. PubMed ID: 31924126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota disruption in critically ill patients : Discussion on "Critically ill patients demonstrate large interpersonal variation of intestinal microbiota dysregulation: a pilot study".
    Iapichino G; Lankelma JM; Joost Wiersinga W
    Intensive Care Med; 2017 May; 43(5):718-719. PubMed ID: 28233052
    [No Abstract]   [Full Text] [Related]  

  • 12. Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients.
    Ojima M; Motooka D; Shimizu K; Gotoh K; Shintani A; Yoshiya K; Nakamura S; Ogura H; Iida T; Shimazu T
    Dig Dis Sci; 2016 Jun; 61(6):1628-34. PubMed ID: 26715502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness.
    Zaborin A; Smith D; Garfield K; Quensen J; Shakhsheer B; Kade M; Tirrell M; Tiedje J; Gilbert JA; Zaborina O; Alverdy JC
    mBio; 2014 Sep; 5(5):e01361-14. PubMed ID: 25249279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Microbiome and Metabolome of the Gut of Children with Sepsis and Septic Shock.
    Sankar J; Thakral V; Bharadwaj K; Agarwal S; Kabra SK; Lodha R; Rathore S
    J Intensive Care Med; 2024 Jun; 39(6):514-524. PubMed ID: 38073164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.
    Lankelma JM; Cranendonk DR; Belzer C; de Vos AF; de Vos WM; van der Poll T; Wiersinga WJ
    Gut; 2017 Sep; 66(9):1623-1630. PubMed ID: 27307305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the fecal microbiota of infants with botulism.
    Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
    Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients.
    Ravi A; Halstead FD; Bamford A; Casey A; Thomson NM; van Schaik W; Snelson C; Goulden R; Foster-Nyarko E; Savva GM; Whitehouse T; Pallen MJ; Oppenheim BA
    Microb Genom; 2019 Sep; 5(9):. PubMed ID: 31526447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
    Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
    J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.
    Wei Y; Yang J; Wang J; Yang Y; Huang J; Gong H; Cui H; Chen D
    Crit Care; 2016 Oct; 20(1):332. PubMed ID: 27751177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report.
    Li Q; Wang C; Tang C; He Q; Zhao X; Li N; Li J
    Crit Care; 2015 Feb; 19(1):37. PubMed ID: 25881250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.